FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a percutaneously absorbable preparation comprising 2-[(1-benzylpiperidin-4-yl)methyl]-5,6~dimethoxyindan-1-one and/or its hydrochloride in a pressure-sensitive adhesive layer, wherein the percutaneously absorbable preparation may be administered into a patient so that Cmax per a surface area unit of the percutaneously absorbable preparation is 0.025 to 0.5 ng/ml·cm2 in the plasma concentration profile. The preparation has a favourable plasma concentration profile of 2-[(1-benzylpiperidin-4-yl)methyl]-5,6~dimethoxyindan-1-one and/or its hydrochloride with no jump of the plasma concentration.
EFFECT: what is presented is the percutaneously absorbable preparation.
29 cl, 1 tbl, 2 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING S-ADENOSYLMETHIONINE, AND ETHERS OF GALLIC ACID | 2013 |
|
RU2586300C1 |
| PERCUTANEOUS DELIVERY SYSTEM, USING MICROPOROUS MEMBRANE CONTAINING PORES FILLED WITH SOLVENT | 2018 |
|
RU2789194C2 |
| AMPHETAMINE PRODRUGS WITH MISUSE PROTECTION | 2006 |
|
RU2445085C2 |
| TACROLIMUS FOR IMPROVED TREATMENT OF PATIENTS WITH GRAFTS | 2009 |
|
RU2574006C2 |
| DEXTROMETHORPHAN TRANSDERMAL DELIVERY DEVICE | 2018 |
|
RU2795729C2 |
| ESLICARBAZEPINE ACETATE AND METHODS FOR APPLYING THEREOF | 2005 |
|
RU2417085C2 |
| GUANFACINE-BASED PHARMACEUTICAL COMPOSITIONS, SUITABLE FOR DAILY INTRODUCTION IN FORM OF SINGLE DOSED FORM | 2006 |
|
RU2435573C2 |
| ADHESIVE PRODUCT | 2007 |
|
RU2441649C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HELICOBACTER PYLORI | 2014 |
|
RU2671400C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM | 2006 |
|
RU2450805C2 |
